PT Bundamedik Tbk (BMHS.JK)
IDR 246.0
(2.5%)
IDR 246.0
(2.5%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 610.99 Billion IDR | 33.42% |
| 2022 | 457.96 Billion IDR | 102.67% |
| 2021 | 225.96 Billion IDR | -41.46% |
| 2020 | 386 Billion IDR | -12.91% |
| 2019 | 443.21 Billion IDR | -8.18% |
| 2018 | 482.69 Billion IDR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 691.76 Billion IDR | 10.39% |
| 2024 Q1 | 705.53 Billion IDR | 2.56% |
| 2024 Q3 | 721.51 Billion IDR | 4.3% |
| 2023 Q2 | 485.68 Billion IDR | 1.93% |
| 2023 Q1 | 476.49 Billion IDR | 4.05% |
| 2023 FY | 610.99 Billion IDR | 33.42% |
| 2023 Q4 | 610.99 Billion IDR | 0.93% |
| 2023 Q3 | 605.38 Billion IDR | 24.65% |
| 2022 Q2 | 439.57 Billion IDR | 15.84% |
| 2022 Q1 | 379.45 Billion IDR | 67.93% |
| 2022 FY | 457.96 Billion IDR | 102.67% |
| 2022 Q4 | 457.96 Billion IDR | 4.28% |
| 2022 Q3 | 439.15 Billion IDR | -0.09% |
| 2021 FY | 225.96 Billion IDR | -41.46% |
| 2021 Q4 | 225.96 Billion IDR | 162.77% |
| 2021 Q3 | 85.99 Billion IDR | -77.35% |
| 2021 Q2 | 379.63 Billion IDR | 0.0% |
| 2021 Q1 | - IDR | -100.0% |
| 2020 Q4 | 386 Billion IDR | 0.0% |
| 2020 FY | 386 Billion IDR | -12.91% |
| 2020 Q1 | - IDR | 0.0% |
| 2019 FY | 443.21 Billion IDR | -8.18% |
| 2018 FY | 482.69 Billion IDR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| PT Metro Healthcare Indonesia Tbk | 129.65 Billion IDR | -371.235% |
| PT Medikaloka Hermina Tbk | 2000.84 Billion IDR | 69.463% |
| PT Mitra Keluarga Karyasehat Tbk | 1.91 Billion IDR | -31794.067% |
| PT Murni Sadar Tbk | 335.53 Billion IDR | -82.097% |
| PT Famon Awal Bros Sedaya Tbk | 1070.65 Billion IDR | 42.933% |
| PT Royal Prima Tbk | - IDR | -Infinity% |
| PT Kedoya Adyaraya Tbk | - IDR | -Infinity% |
| PT Sarana Meditama Metropolitan Tbk | 681.42 Billion IDR | 10.336% |
| PT Siloam International Hospitals Tbk | 151.97 Billion IDR | -302.041% |
| PT Sejahteraraya Anugrahjaya Tbk | 1542.29 Billion IDR | 60.384% |